FindTrial
Sign In

A comparison of anesthetic quality and complication between single injection and double injection of costoclavicular approach in upper extremity surgery

A comparison of anesthetic quality and complication between single injection and double injection of costoclavicular approach in upper extremity surgery - single vs. double costoclavicular approach

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000043880
Enrollment
68
Registered
2021-04-09
Start date
2021-04-19
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

upper extreimity surgery

Interventions

Interventions: double injection of costoclavicular approach 21G, 68mm E-cath needle (Pajunk) Nerve stimulator GE ultrasound Control: single injection of costoclavicular approach

Sponsors

Korea University Anam Hospital Gachon University Gil Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: all patients anticipating upper extremity surgery, age: 19 to 80 years, American Society of Anesthesiologists physical status (ASA)I to III

Exclusion criteria

Exclusion criteria: neuropathy in the operated limb, coagulation disorders, known allergy to local anesthetics, local infection at the puncture site, chronic obstructive pulmonary disease or respiratory failure, pregnancy or breast feeding,prior surgery in the supraclavicular region, obesity, uncooperative patients, patients' refusal

Design outcomes

Primary

MeasureTime frame
success rate (excellent, insufficient, fail) the rate of blockage of all four nerves—

Secondary

MeasureTime frame
the onset time (time required to obtain a full sensory block at the surgical incision site)—

Countries

Asia(except Japan)

Contacts

Public ContactHyeon Ju Shin

Korea University College of Medicine, Anam hospital The Anesthesiology and Pain medicine

may335@naver.com+82-2-2286-1259

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026